Development of Stable, Maleimide-Functionalized Peptidoliposomes Against SARS-CoV-2
International Journal of Molecular Sciences · 14.02.2025 · 26 (4) · 1629
DOI: 10.3390/ijms26041629 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 14.02.2025. Verfasst von Olga Michel und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cytobiochemistry, Faculty of Biotechnology, University of Wrocław, F. Joliot Curie 14a, 50-383 Wrocław, Poland. Hauptthemen laut MEDLINE: Liposomes, SARS-CoV-2, Maleimides, Antiviral Agents. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 109 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical Research Agency (Poland).
Abstract (Originalsprache)
Throughout the last 5 years, extensive research has been carried out towards the development of effective treatments for coronavirus disease 2019 (COVID-19). Regardless of the worldwide efforts, only a few drugs have passed clinical trials, and there is still a need to develop therapies, especially for those who are particularly vulnerable to a severe disease course. Maleimide-functionalized liposomes are proposed to serve as a platform for the immobilization, stabilization, and delivery of a short peptide sequence with high affinity towards severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). However, extensive optimizations should be performed in order to achieve features required for a reliable drug candidate, such as homogeneity of physical parameters and their long-term stability. Here, we present a step-by-step development process for maleimide-functionalized liposomes, which—once decorated with the SARS-CoV-2-binding peptide—could inhibit the infection progress of COVID-19. The main emphasis is placed on defining optimal lipid composition and formation conditions of PEGylated liposomes. We propose that the developed nanocarrier technology can be used as a universal platform for the construction of multiple antiviral agents.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cytobiochemistry, Faculty of Biotechnology, University of Wrocław, F. Joliot Curie 14a, 50-383 Wrocław, Poland.
- Department of Biomedical Engineering, Faculty of Fundamental Problems of Technology, Wrocław University of Science and Technology, Wybrzeże S. Wyspiańskiego 27, 50-370 Wrocław, Poland.
- Silesian Park of Medical Technology Kardio-Med Silesia, M. Curie-Skłodowskiej 10C, 41-800 Zabrze, Poland.
- Acellmed Ltd., M. Curie-Skłodowskiej 10C, 41-800 Zabrze, Poland.
- Research and Development Center, Regional Specialist Hospital, Kamienskiego 73a, 51-154 Wrocław, Poland.
ORCID-Profile: Olga Michel, Aleksandra Kaczorowska, Marlena Golec, Kazimierz Kuliczkowski, Aleksander F Sikorski, Aleksander Czogalla
Förderung
- Medical Research Agency (Poland)
Zitieren
APA
Michel, O., Kaczorowska, A., Matusewicz, L., Piórkowska, K., Golec, M., Fus, W., Kuliczkowski, K., Sikorski, A. F., & Czogalla, A. (2025). Development of Stable, Maleimide-Functionalized Peptidoliposomes Against SARS-CoV-2. International Journal of Molecular Sciences, 26(4), 1629. https://doi.org/10.3390/ijms26041629
Vancouver
Michel O, Kaczorowska A, Matusewicz L, Piórkowska K, Golec M, Fus W, et al. Development of Stable, Maleimide-Functionalized Peptidoliposomes Against SARS-CoV-2. International Journal of Molecular Sciences. 2025;26(4):1629. doi:10.3390/ijms26041629
BibTeX
@article{Michel2025,
author = {Michel, Olga and Kaczorowska, Aleksandra and Matusewicz, Lucyna and Piórkowska, Kliwia and Golec, Marlena and Fus, Wiktoria and Kuliczkowski, Kazimierz and Sikorski, Aleksander F and Czogalla, Aleksander},
title = {Development of Stable, Maleimide-Functionalized Peptidoliposomes Against SARS-CoV-2},
journal = {International Journal of Molecular Sciences},
year = {2025},
volume = {26},
number = {4},
pages = {1629},
doi = {10.3390/ijms26041629}
}
EUVIMED